[CLDX] YoY Annual Result on 31-Dec-2015 [#FY]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
23-Feb-2016
Financial Year
2015
Quarter
31-Dec-2015 [#FY]
Profit Trend
YoY- -7.72%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Annual Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 9,538 12,743 6,786 5,480 3,586 4,111 11,202 -2.64%
PBT -151,949 -117,313 -128,530 -127,197 -118,080 -81,550 -59,123 17.02%
Tax -765 -24,282 -8,772 -2,344 -4,350 -819 -530 6.30%
NP -151,184 -93,031 -128,530 -127,197 -118,080 -81,550 -59,123 16.93%
Tax Rate - - - - - - - -
Total Cost 160,722 105,774 135,316 132,677 121,666 85,661 70,325 14.76%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin -1,585.07 -730.06 -1,894.05 -2,321.11 -3,292.81 -1,983.70 -527.79 20.10%
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS -14.48 -10.86 -18.99 -19.66 -19.81 -15.33 -15.37 -0.98%
EPS Diluted -14.48 -10.86 -18.99 -19.66 -19.81 -15.33 -15.37 -0.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.